CLIC4 Function in the Epithelial-Mesenchymal Transition of Epithelial Odontogenic Lesions
Head and Neck Pathology · 2024
DOI: 10.1007/s12105-024-01646-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head and Neck Pathology, 2024. Verfasst von Mariana Carvalho Xerez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Oral Pathology and Medicine, Postgraduate Program in Dental Sciences, Department of Dentistry, Federal University of Rio Grande do Norte, Natal, RN, …. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Chloride Channels, Cadherins, Odontogenic Tumors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Odontogenic lesions constitute a heterogeneous group of lesions. CLIC4 protein regulates different cellular processes, including epithelial-mesenchymal transition and fibroblast-myofibroblast transdifferentiation. This study analyzed CLIC4, E-cadherin, Vimentin, and α-SMA immunoexpression in epithelial odontogenic lesions that exhibit different biological behavior. METHODS: It analyzed the immunoexpression of CLIC4, E-cadherin, and Vimentin in the epithelial cells, as well as CLIC4 and α-SMA in the mesenchymal cells, of ameloblastoma (AM) (n = 16), odontogenic keratocyst (OKC) (n = 20), and adenomatoid odontogenic tumor (AOT) (n = 8). Immunoexpressions were categorized as score 0 (0% positive cells), 1 (< 25%), 2 (≥ 25% - < 50%), 3 (≥ 50% - < 75%), or 4 (≥ 75%). RESULTS: Cytoplasmic CLIC4 immunoexpression was higher in AM and AOT (p < 0.001) epithelial cells. Nuclear-cytoplasmic CLIC4 was higher in OKC's epithelial lining (p < 0.001). Membrane (p = 0.012) and membrane-cytoplasmic (p < 0.001) E-cadherin immunoexpression were higher in OKC, while cytoplasmic E-cadherin expression was higher in AM and AOT (p < 0.001). Vimentin immunoexpression was higher in AM and AOT (p < 0.001). Stromal CLIC4 was higher in AM and OKC (p = 0.008). Similarly, α-SMA immunoexpression was higher in AM and OKC (p = 0.037). Correlations in these proteins' immunoexpression were observed in AM and OKC (p < 0.05). CONCLUSIONS: CLIC4 seems to regulate the epithelial-mesenchymal transition, modifying E-cadherin and Vimentin expression. In mesenchymal cells, CLIC4 may play a role in fibroblast-myofibroblast transdifferentiation. CLIC4 may be associated with epithelial odontogenic lesions with aggressive biological behavior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oral Pathology and Medicine, Postgraduate Program in Dental Sciences, Department of Dentistry, Federal University of Rio Grande do Norte, Natal, RN, Brazil. m.carvalhoxerez@gmail.com.
- Oral Pathology and Medicine, Postgraduate Program in Dental Sciences, Department of Dentistry, Federal University of Rio Grande do Norte, Natal, RN, Brazil.
- Department of Dentistry, Federal University of Rio Grande do Norte, Av. Salgado Filho, 1787, Lagoa Nova, Natal, CEP: 59056-000, RN, Brazil.
Zitieren
APA
Xerez, M. C., da Silva Barros, C. C., de Souto Medeiros, M. R., Mafra, R. P., de Lucena, H. F., da Silveira, É. J. D., & de Lisboa Lopes Costa, A. (2024). CLIC4 Function in the Epithelial-Mesenchymal Transition of Epithelial Odontogenic Lesions. Head and Neck Pathology. https://doi.org/10.1007/s12105-024-01646-1
Vancouver
Xerez MC, da Silva Barros CC, de Souto Medeiros MR, Mafra RP, de Lucena HF, da Silveira ÉJD, et al. CLIC4 Function in the Epithelial-Mesenchymal Transition of Epithelial Odontogenic Lesions. Head and Neck Pathology. 2024. doi:10.1007/s12105-024-01646-1
BibTeX
@article{Xerez2024,
author = {Xerez, Mariana Carvalho and da Silva Barros, Caio César and de Souto Medeiros, Maurília Raquel and Mafra, Rodrigo Porpino and de Lucena, Hévio Freitas and da Silveira, Éricka Janine Dantas and de Lisboa Lopes Costa, Antonio},
title = {CLIC4 Function in the Epithelial-Mesenchymal Transition of Epithelial Odontogenic Lesions},
journal = {Head and Neck Pathology},
year = {2024},
doi = {10.1007/s12105-024-01646-1}
}
EUVIMED